CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma
1 clinical trials · Condition
◉ Watch CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma (NCT01933711) | University Hospital Heidelberg | 2002-07-01 |
Track CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.